Your browser doesn't support javascript.
loading
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
de Roest, Reinout H; van der Heijden, Martijn; Wesseling, Frederik W R; de Ruiter, Emma J; Heymans, Martijn W; Terhaard, Chris; Vergeer, Marije R; Buter, Jan; Devriese, Lot A; de Boer, Jan Paul; Navran, Arash; Hoeben, Ann; Vens, Conchita; van den Brekel, Michiel; Brakenhoff, Ruud H; Leemans, C René; Hoebers, Frank.
Afiliação
  • de Roest RH; Amsterdam UMC, Vrije Universiteit Amsterdam, Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, The Netherlands. Electronic address: r.deroest@amsterdamumc.nl.
  • van der Heijden M; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wesseling FWR; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • de Ruiter EJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Heymans MW; Department of Epidemiology and Data Science, Amsterdam UMC, Location VU University Medical Center, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Terhaard C; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Vergeer MR; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.
  • Buter J; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Oncology, Amsterdam, The Netherlands.
  • Devriese LA; Department of Medical Oncology, Division of Imaging and Oncology, University Medical Center Utrecht and Utrecht University, The Netherlands.
  • de Boer JP; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Navran A; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hoeben A; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center+, GROW - School for Oncology and De
  • Vens C; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van den Brekel M; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, Academic Medical Center, Amsterdam, The Netherlands.
  • Brakenhoff RH; Amsterdam UMC, Vrije Universiteit Amsterdam, Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, The Netherlands.
  • Leemans CR; Amsterdam UMC, Vrije Universiteit Amsterdam, Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, The Netherlands.
  • Hoebers F; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Radiother Oncol ; 175: 112-121, 2022 10.
Article em En | MEDLINE | ID: mdl-35973619

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Infecções por Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Infecções por Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2022 Tipo de documento: Article